SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-081167
Filing Date
2024-07-19
Accepted
2024-07-19 16:15:05
Documents
6
Period of Report
2024-09-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2419085-1_def14a.htm DEF 14A 932086
2 GRAPHIC lg_replimuereg-4c.jpg GRAPHIC 29211
3 GRAPHIC bc_capvstsr-4clr.jpg GRAPHIC 52833
4 GRAPHIC bc_capvsnetloss-4clr.jpg GRAPHIC 45507
5 GRAPHIC px_24replimunepxy01pg01-4c.jpg GRAPHIC 270619
6 GRAPHIC px_24replimunepxy01pg02-4c.jpg GRAPHIC 344403
  Complete submission text file 0001104659-24-081167.txt   1896605
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38596 | Film No.: 241127949
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)